Global Polymers Drug Delivery

Polymers Drug Delivery Comprehensive Study by Type (Micelles, Microgels, Dendrimer, Hydrogels, Others), Application (Hospitals, Medical Research Center, Pharmaceutical Factory, Others), Formulations (Conventional Drug Delivery Formulations, Novel Drug Delivery Formulations), Distribution Channel (Hospitals, Retail Pharmacy Stores) Players and Region - Global Market Outlook to 2026

Polymers Drug Delivery Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Polymers have played an integral role in the advancement of drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. The global polymers drug delivery market is growing significantly due to rising geriatric population, technological advancements in polymers drug delivery and increase in the number of cancer and diabetic patients globally. Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body which increases efficiency and better patient experience. The advent of new technologies is expected to play a pivotal role in the growth of the global drug delivery market.This growth is primarily driven by Rising Prevalence of Chronic Diseases and Growth in the Biologics Market.

Globally, a noticeable market trend is evident Innovations in Polymers Drug Delivery Systems. Major Players, such as Sanofi (France), Inovio Pharmaceuticals (United States), Alkermes (Ireland), Janssen Biotech (United States), Heron (United States), Eisai (Japan), Perrigo (United States), Quark Pharmaceuticals Inc (Israel), Vectura Group Plc (United Kingdom) and SurModics (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Rising Prevalence of Chronic Diseases
  • Growth in the Biologics Market

Market Trend
  • Innovations in Polymers Drug Delivery Systems

Restraints
  • Lack of Skilled and Trained Professional Hampers the Polymers Drug Delivery System Market
  • Dosage Error Leads to Restrain the Market

Opportunities
Self-Administration and Home Care
Challenges
Limitation Due to Product Recall are Anticipated to Challenge the Market and Substitutes Available Threat the Polymers Drug Delivery System Market

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Polymers Drug Delivery Study Sheds Light on
— The Polymers Drug Delivery Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Polymers Drug Delivery industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Polymers Drug Delivery industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Micelles
  • Microgels
  • Dendrimer
  • Hydrogels
  • Others
By Application
  • Hospitals
  • Medical Research Center
  • Pharmaceutical Factory
  • Others
By Formulations
  • Conventional Drug Delivery Formulations
  • Novel Drug Delivery Formulations

By Distribution Channel
  • Hospitals
  • Retail Pharmacy Stores

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Diseases
      • 3.2.2. Growth in the Biologics Market
    • 3.3. Market Challenges
      • 3.3.1. Limitation Due to Product Recall are Anticipated to Challenge the Market
      • 3.3.2. Substitutes Available Threat the Polymers Drug Delivery System Market
    • 3.4. Market Trends
      • 3.4.1. Innovations in Polymers Drug Delivery Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Polymers Drug Delivery, by Type, Application, Formulations, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Polymers Drug Delivery (Value)
      • 5.2.1. Global Polymers Drug Delivery by: Type (Value)
        • 5.2.1.1. Micelles
        • 5.2.1.2. Microgels
        • 5.2.1.3. Dendrimer
        • 5.2.1.4. Hydrogels
        • 5.2.1.5. Others
      • 5.2.2. Global Polymers Drug Delivery by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Medical Research Center
        • 5.2.2.3. Pharmaceutical Factory
        • 5.2.2.4. Others
      • 5.2.3. Global Polymers Drug Delivery by: Formulations (Value)
        • 5.2.3.1. Conventional Drug Delivery Formulations
        • 5.2.3.2. Novel Drug Delivery Formulations
      • 5.2.4. Global Polymers Drug Delivery by: Distribution Channel (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Retail Pharmacy Stores
      • 5.2.5. Global Polymers Drug Delivery Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Polymers Drug Delivery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sanofi (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Inovio Pharmaceuticals (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alkermes (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Janssen Biotech (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Heron (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Eisai (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Perrigo (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Quark Pharmaceuticals Inc (Israel)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Vectura Group Plc (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. SurModics (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Polymers Drug Delivery Sale, by Type, Application, Formulations, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Polymers Drug Delivery (Value)
      • 7.2.1. Global Polymers Drug Delivery by: Type (Value)
        • 7.2.1.1. Micelles
        • 7.2.1.2. Microgels
        • 7.2.1.3. Dendrimer
        • 7.2.1.4. Hydrogels
        • 7.2.1.5. Others
      • 7.2.2. Global Polymers Drug Delivery by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Medical Research Center
        • 7.2.2.3. Pharmaceutical Factory
        • 7.2.2.4. Others
      • 7.2.3. Global Polymers Drug Delivery by: Formulations (Value)
        • 7.2.3.1. Conventional Drug Delivery Formulations
        • 7.2.3.2. Novel Drug Delivery Formulations
      • 7.2.4. Global Polymers Drug Delivery by: Distribution Channel (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Retail Pharmacy Stores
      • 7.2.5. Global Polymers Drug Delivery Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Polymers Drug Delivery: by Type(USD Million)
  • Table 2. Polymers Drug Delivery Micelles , by Region USD Million (2015-2020)
  • Table 3. Polymers Drug Delivery Microgels , by Region USD Million (2015-2020)
  • Table 4. Polymers Drug Delivery Dendrimer , by Region USD Million (2015-2020)
  • Table 5. Polymers Drug Delivery Hydrogels , by Region USD Million (2015-2020)
  • Table 6. Polymers Drug Delivery Others , by Region USD Million (2015-2020)
  • Table 7. Polymers Drug Delivery: by Application(USD Million)
  • Table 8. Polymers Drug Delivery Hospitals , by Region USD Million (2015-2020)
  • Table 9. Polymers Drug Delivery Medical Research Center , by Region USD Million (2015-2020)
  • Table 10. Polymers Drug Delivery Pharmaceutical Factory , by Region USD Million (2015-2020)
  • Table 11. Polymers Drug Delivery Others , by Region USD Million (2015-2020)
  • Table 12. Polymers Drug Delivery: by Formulations(USD Million)
  • Table 13. Polymers Drug Delivery Conventional Drug Delivery Formulations , by Region USD Million (2015-2020)
  • Table 14. Polymers Drug Delivery Novel Drug Delivery Formulations , by Region USD Million (2015-2020)
  • Table 15. Polymers Drug Delivery: by Distribution Channel(USD Million)
  • Table 16. Polymers Drug Delivery Hospitals , by Region USD Million (2015-2020)
  • Table 17. Polymers Drug Delivery Retail Pharmacy Stores , by Region USD Million (2015-2020)
  • Table 18. South America Polymers Drug Delivery, by Country USD Million (2015-2020)
  • Table 19. South America Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 20. South America Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 21. South America Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 22. South America Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 23. Brazil Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 24. Brazil Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 25. Brazil Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 26. Brazil Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 27. Argentina Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 28. Argentina Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 29. Argentina Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 30. Argentina Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 31. Rest of South America Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 32. Rest of South America Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 33. Rest of South America Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 34. Rest of South America Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 35. Asia Pacific Polymers Drug Delivery, by Country USD Million (2015-2020)
  • Table 36. Asia Pacific Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 37. Asia Pacific Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 38. Asia Pacific Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 39. Asia Pacific Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 40. China Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 41. China Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 42. China Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 43. China Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 44. Japan Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 45. Japan Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 46. Japan Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 47. Japan Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 48. India Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 49. India Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 50. India Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 51. India Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 52. South Korea Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 53. South Korea Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 54. South Korea Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 55. South Korea Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 56. Taiwan Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 57. Taiwan Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 58. Taiwan Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 59. Taiwan Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 60. Australia Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 61. Australia Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 62. Australia Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 63. Australia Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 68. Europe Polymers Drug Delivery, by Country USD Million (2015-2020)
  • Table 69. Europe Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 70. Europe Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 71. Europe Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 72. Europe Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 73. Germany Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 74. Germany Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 75. Germany Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 76. Germany Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 77. France Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 78. France Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 79. France Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 80. France Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 81. Italy Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 82. Italy Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 83. Italy Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 84. Italy Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 85. United Kingdom Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 86. United Kingdom Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 87. United Kingdom Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 88. United Kingdom Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 89. Netherlands Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 90. Netherlands Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 91. Netherlands Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 92. Netherlands Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 93. Rest of Europe Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 94. Rest of Europe Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 95. Rest of Europe Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 96. Rest of Europe Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 97. MEA Polymers Drug Delivery, by Country USD Million (2015-2020)
  • Table 98. MEA Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 99. MEA Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 100. MEA Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 101. MEA Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 102. Middle East Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 103. Middle East Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 104. Middle East Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 105. Middle East Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 106. Africa Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 107. Africa Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 108. Africa Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 109. Africa Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 110. North America Polymers Drug Delivery, by Country USD Million (2015-2020)
  • Table 111. North America Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 112. North America Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 113. North America Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 114. North America Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 115. United States Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 116. United States Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 117. United States Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 118. United States Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 119. Canada Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 120. Canada Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 121. Canada Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 122. Canada Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 123. Mexico Polymers Drug Delivery, by Type USD Million (2015-2020)
  • Table 124. Mexico Polymers Drug Delivery, by Application USD Million (2015-2020)
  • Table 125. Mexico Polymers Drug Delivery, by Formulations USD Million (2015-2020)
  • Table 126. Mexico Polymers Drug Delivery, by Distribution Channel USD Million (2015-2020)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Polymers Drug Delivery: by Type(USD Million)
  • Table 138. Polymers Drug Delivery Micelles , by Region USD Million (2021-2026)
  • Table 139. Polymers Drug Delivery Microgels , by Region USD Million (2021-2026)
  • Table 140. Polymers Drug Delivery Dendrimer , by Region USD Million (2021-2026)
  • Table 141. Polymers Drug Delivery Hydrogels , by Region USD Million (2021-2026)
  • Table 142. Polymers Drug Delivery Others , by Region USD Million (2021-2026)
  • Table 143. Polymers Drug Delivery: by Application(USD Million)
  • Table 144. Polymers Drug Delivery Hospitals , by Region USD Million (2021-2026)
  • Table 145. Polymers Drug Delivery Medical Research Center , by Region USD Million (2021-2026)
  • Table 146. Polymers Drug Delivery Pharmaceutical Factory , by Region USD Million (2021-2026)
  • Table 147. Polymers Drug Delivery Others , by Region USD Million (2021-2026)
  • Table 148. Polymers Drug Delivery: by Formulations(USD Million)
  • Table 149. Polymers Drug Delivery Conventional Drug Delivery Formulations , by Region USD Million (2021-2026)
  • Table 150. Polymers Drug Delivery Novel Drug Delivery Formulations , by Region USD Million (2021-2026)
  • Table 151. Polymers Drug Delivery: by Distribution Channel(USD Million)
  • Table 152. Polymers Drug Delivery Hospitals , by Region USD Million (2021-2026)
  • Table 153. Polymers Drug Delivery Retail Pharmacy Stores , by Region USD Million (2021-2026)
  • Table 154. South America Polymers Drug Delivery, by Country USD Million (2021-2026)
  • Table 155. South America Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 156. South America Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 157. South America Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 158. South America Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 159. Brazil Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 160. Brazil Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 161. Brazil Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 162. Brazil Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 163. Argentina Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 164. Argentina Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 165. Argentina Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 166. Argentina Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 167. Rest of South America Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 168. Rest of South America Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 169. Rest of South America Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 170. Rest of South America Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 171. Asia Pacific Polymers Drug Delivery, by Country USD Million (2021-2026)
  • Table 172. Asia Pacific Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 173. Asia Pacific Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 174. Asia Pacific Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 175. Asia Pacific Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 176. China Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 177. China Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 178. China Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 179. China Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 180. Japan Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 181. Japan Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 182. Japan Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 183. Japan Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 184. India Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 185. India Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 186. India Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 187. India Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 188. South Korea Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 189. South Korea Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 190. South Korea Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 191. South Korea Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 192. Taiwan Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 193. Taiwan Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 194. Taiwan Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 195. Taiwan Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 196. Australia Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 197. Australia Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 198. Australia Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 199. Australia Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 200. Rest of Asia-Pacific Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 201. Rest of Asia-Pacific Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 202. Rest of Asia-Pacific Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 204. Europe Polymers Drug Delivery, by Country USD Million (2021-2026)
  • Table 205. Europe Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 206. Europe Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 207. Europe Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 208. Europe Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 209. Germany Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 210. Germany Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 211. Germany Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 212. Germany Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 213. France Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 214. France Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 215. France Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 216. France Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 217. Italy Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 218. Italy Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 219. Italy Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 220. Italy Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 221. United Kingdom Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 222. United Kingdom Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 223. United Kingdom Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 224. United Kingdom Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 225. Netherlands Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 226. Netherlands Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 227. Netherlands Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 228. Netherlands Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 229. Rest of Europe Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 230. Rest of Europe Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 231. Rest of Europe Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 232. Rest of Europe Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 233. MEA Polymers Drug Delivery, by Country USD Million (2021-2026)
  • Table 234. MEA Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 235. MEA Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 236. MEA Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 237. MEA Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 238. Middle East Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 239. Middle East Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 240. Middle East Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 241. Middle East Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 242. Africa Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 243. Africa Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 244. Africa Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 245. Africa Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 246. North America Polymers Drug Delivery, by Country USD Million (2021-2026)
  • Table 247. North America Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 248. North America Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 249. North America Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 250. North America Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 251. United States Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 252. United States Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 253. United States Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 254. United States Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 255. Canada Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 256. Canada Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 257. Canada Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 258. Canada Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 259. Mexico Polymers Drug Delivery, by Type USD Million (2021-2026)
  • Table 260. Mexico Polymers Drug Delivery, by Application USD Million (2021-2026)
  • Table 261. Mexico Polymers Drug Delivery, by Formulations USD Million (2021-2026)
  • Table 262. Mexico Polymers Drug Delivery, by Distribution Channel USD Million (2021-2026)
  • Table 263. Research Programs/Design for This Report
  • Table 264. Key Data Information from Secondary Sources
  • Table 265. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Polymers Drug Delivery: by Type USD Million (2015-2020)
  • Figure 5. Global Polymers Drug Delivery: by Application USD Million (2015-2020)
  • Figure 6. Global Polymers Drug Delivery: by Formulations USD Million (2015-2020)
  • Figure 7. Global Polymers Drug Delivery: by Distribution Channel USD Million (2015-2020)
  • Figure 8. South America Polymers Drug Delivery Share (%), by Country
  • Figure 9. Asia Pacific Polymers Drug Delivery Share (%), by Country
  • Figure 10. Europe Polymers Drug Delivery Share (%), by Country
  • Figure 11. MEA Polymers Drug Delivery Share (%), by Country
  • Figure 12. North America Polymers Drug Delivery Share (%), by Country
  • Figure 13. Global Polymers Drug Delivery share by Players 2020 (%)
  • Figure 14. Global Polymers Drug Delivery share by Players (Top 3) 2020(%)
  • Figure 15. Global Polymers Drug Delivery share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 18. Sanofi (France) Revenue: by Geography 2020
  • Figure 19. Inovio Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 20. Inovio Pharmaceuticals (United States) Revenue: by Geography 2020
  • Figure 21. Alkermes (Ireland) Revenue, Net Income and Gross profit
  • Figure 22. Alkermes (Ireland) Revenue: by Geography 2020
  • Figure 23. Janssen Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 24. Janssen Biotech (United States) Revenue: by Geography 2020
  • Figure 25. Heron (United States) Revenue, Net Income and Gross profit
  • Figure 26. Heron (United States) Revenue: by Geography 2020
  • Figure 27. Eisai (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Eisai (Japan) Revenue: by Geography 2020
  • Figure 29. Perrigo (United States) Revenue, Net Income and Gross profit
  • Figure 30. Perrigo (United States) Revenue: by Geography 2020
  • Figure 31. Quark Pharmaceuticals Inc (Israel) Revenue, Net Income and Gross profit
  • Figure 32. Quark Pharmaceuticals Inc (Israel) Revenue: by Geography 2020
  • Figure 33. Vectura Group Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Vectura Group Plc (United Kingdom) Revenue: by Geography 2020
  • Figure 35. SurModics (United States) Revenue, Net Income and Gross profit
  • Figure 36. SurModics (United States) Revenue: by Geography 2020
  • Figure 37. Global Polymers Drug Delivery: by Type USD Million (2021-2026)
  • Figure 38. Global Polymers Drug Delivery: by Application USD Million (2021-2026)
  • Figure 39. Global Polymers Drug Delivery: by Formulations USD Million (2021-2026)
  • Figure 40. Global Polymers Drug Delivery: by Distribution Channel USD Million (2021-2026)
  • Figure 41. South America Polymers Drug Delivery Share (%), by Country
  • Figure 42. Asia Pacific Polymers Drug Delivery Share (%), by Country
  • Figure 43. Europe Polymers Drug Delivery Share (%), by Country
  • Figure 44. MEA Polymers Drug Delivery Share (%), by Country
  • Figure 45. North America Polymers Drug Delivery Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sanofi (France)
  • Inovio Pharmaceuticals (United States)
  • Alkermes (Ireland)
  • Janssen Biotech (United States)
  • Heron (United States)
  • Eisai (Japan)
  • Perrigo (United States)
  • Quark Pharmaceuticals Inc (Israel)
  • Vectura Group Plc (United Kingdom)
  • SurModics (United States)
Additional players considered in the study are as follows:
EnColl Corporation , Enzon Pharmaceuticals , Nektar Therapeutics , Allergan , Gilead Sciences , Tolmar
Select User Access Type

Key Highlights of Report


Sep 2021 200 Pages 61 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Polymers Drug Delivery Quantitative research analysis
Global Polymers Drug Delivery Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Polymers Drug Delivery Market are Sanofi (France), Inovio Pharmaceuticals (United States), Alkermes (Ireland), Janssen Biotech (United States), Heron (United States), Eisai (Japan), Perrigo (United States), Quark Pharmaceuticals Inc (Israel), Vectura Group Plc (United Kingdom) and SurModics (United States) etc.
Polymers have played an integral role in the advancement of drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. The global polymers drug delivery market is growing significantly due to rising geriatric population, technological advancements in polymers drug delivery and increase in the number of cancer and diabetic patients globally. Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body which increases efficiency and better patient experience. The advent of new technologies is expected to play a pivotal role in the growth of the global drug delivery market.

Know More About Global Polymers Drug Delivery Report?

Have a Query? Click Here

Other Related Reports

Plant Activators Comprehensive Study by Type (Biological Plant Activators, Chemical Plant Activators), Application (Foliar Spray, Soil Treatment, Others), Forms (Solutions, Water-Dispersible & Water-...
$ 3450
Epithelial Stem Cells Comprehensive Study by Type (Absorptive Cells, Goblet Cell, Paneth Cells, Oligodendrocytes), Application (Tissue Repair Damage, Autoimmune Diseases, Others) Players and Region -...
$ 3500
Microbial Inoculants Comprehensive Study by Type (Agricultural Inoculants, Silage Inoculants), Crop Type (Oilseeds & Pulses, Cereals & Grains, Fruits & Vegetables, Forage), Microbes (Bacterial, Funga...
$ 3500
Metabolomics Comprehensive Study by Application (Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical toxicology, Others), Indication (Cancer, Cardiovascular Disorders, Neurological Disorder...
$ 3750
Microbiology Culture Comprehensive Study by Application (Metabolic Production, Biotransformation, Production of Biofuels, Treatment of Industrial Waste), End User Industry (Pharma Industry, Cosmetics...
$ 3750
Thermoplastic Rubber Comprehensive Study by Type (Thermoplastic Olefins, Vulcanized PP/EPDM Compound, Thermoplastic Polyurethane, Styrenic SBS, SEBS or SEPS Compound, Copolyester Compound, Thermoplas...
$ 3750